They are two of the most common noncommunicable diseases in the world, and estimates predict one billion people worldwide are affected by obesity while approximately 521million individuals globally live with diabetes
Cons: Major surgery, long-term nutritional requirements, higher initial risk
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis
What matters most is not the number itself, but how your body responds
However, it also technically belongs to the GLP-1 receptor agonist class, which is the where the confusion arises
Ozempic has become a widely recognized brand name, not just for managing Type 2 diabetes, but also for weight loss